Drug Enforcement D-173-2013

Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.

Status

Terminated

Classification

Class II

Report Date

March 6, 2013

Termination Date

March 21, 2014

Product Information

Product description
Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-329-09
Product quantity
10,968 bottles
Reason for recall
Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide and Puerto Rico.

Location & Firm

Recalling firm
Amedra Pharmaceuticals LLC
Address
2 Walnut Grove Dr, Suite 190

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-173-2013
Event ID
63926
Recall initiation date
December 4, 2012
Center classification date
February 27, 2013
Code info
Lot 220843, exp 11/30/2013
More code info